SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056295
Filing Date
2024-05-09
Accepted
2024-05-09 08:00:33
Documents
67
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pmvp-20240331.htm   iXBRL 10-Q 1284620
2 EX-10.4 pmvp-ex10_4.htm EX-10.4 187747
3 EX-31.1 pmvp-ex31_1.htm EX-31.1 15797
4 EX-31.2 pmvp-ex31_2.htm EX-31.2 15782
5 EX-32.1 pmvp-ex32_1.htm EX-32.1 8486
6 EX-32.2 pmvp-ex32_2.htm EX-32.2 8767
  Complete submission text file 0000950170-24-056295.txt   6362863

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pmvp-20240331.xsd EX-101.SCH 934605
71 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-20240331_htm.xml XML 1080416
Mailing Address ONE RESEARCH WAY PRINCETON NJ 08540
Business Address ONE RESEARCH WAY PRINCETON NJ 08540 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39539 | Film No.: 24928673
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)